Bighorn Web Solutions, a leading enterprise-grade eCommerce agency specializing in conversion rate optimization, platform migrations, ERP integration ...
After President Donald Trump announced new reciprocal trade tariffs, support continues to roll in from across industries and from Opposition quarters.The support is bipartisan ...
Titan Cement International S.A. (Euronext Brussels, ATHEX and Euronext Paris, TITC) announces its updated Financial Calendar for 2025, including the Extraordinary General Meeting ...
The wait is over: the list of cars that will participate in the 1000 Miglia 2025 has been drawn up by the Selection Committee that, year after year, has ...
Enhanced Hole Insights offers more detailed analysis around historic, in-Tournament and projected play for every hole on ...
As per 9 April 2025 the nominal value of the A and B shares issued by Rockwool A/S will be changed and consequently the ISIN codes will be changed. The last day of trading A and B shares with a nomina ...
Boulder Imaging has announced a partnership with Roc Conservation Tech to expand IdentiFlight's global reach and enhance wildlife conservation within ...
Intellego Technologies AB (publ) announces that the Company has already achieved an EBIT result of 160 million SEK for 2025. This goal, announced earlier this year, has now been reached ahead of expec ...
NYKÖPING, SE / ACCESS Newswire / April 4, 2025 / CTT Systems AB (STO:CTT) - CTT Systems' Interim Report for Q1 2025 will be published on April 25 th , 2025, at 08.00 (CEST)The presentation will be web ...
LONDON, GB / ACCESS Newswire / April 4, 2025 / Helium One Global (AIM:HE1), the primary helium explorer in Tanzania with a 50% working interest in the Galactica-Pegasus helium development project in C ...
Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater separation with Alzheimer's pTau217 pathology ...
LUND, SE / ACCESS Newswire / April 4, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class im ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results